Needham & Company LLC Boosts Globant (NYSE:GLOB) Price

1 day ago · Needham & Company LLC lifted their price objective on shares of Globant from $245.00 to $265.00 and gave the company a "buy" rating in a research report on Friday. ...

CouponFollow Extension

$245.00
OFF

Needham & Company LLC Boosts Globant (NYSE:GLOB) Price

1 week from now

1 day ago · Needham & Company LLC lifted their price objective on shares of Globant from $245.00 to $265.00 and gave the company a "buy" rating in a research report on Friday. ...

marketbeat.com

$265
OFF

Globant Shares Get Higher Price Target, Buy Rating On Strong Growth

1 week from now

2 days ago · Friday's trading session began with news that Needham has increased the price target on Globant S.A. (NYSE: GLOB) shares to $265 from the previous $245 while …

investing.com

$265
OFF

Globant Price Target Raised To $265 From $245 At Needham

1 week from now

1 day ago · Needham raised the firm’s price target on Globant (GLOB) to $265 from $245 and keeps a Buy rating on the shares after its Q3 results. The company saw healthy organic FX …

nasdaq.com

96%
OFF

Needham Initiates Coverage Of Globant (GLOB) With Buy ... - Nasdaq

1 week from now

Apr 6, 2023 · Fintel reports that on April 12, 2023, Needham initiated coverage of Globant (NYSE:GLOB) with a Buy recommendation. Analyst Price Forecast Suggests 37.96% Upside. …

nasdaq.com

$265
OFF

Globant Shares Get Higher Price Target, Buy Rating On Strong Growth

1 week from now

2 days ago · Friday's trading session began with news that Needham has increased the price target on Globant S.A. (NYSE: GLOB) shares to $265 from the previous $245 while …

investing.com

$205
OFF

Globant Well-Positioned For Best-In-Breed Organic Growth And …

1 week from now

Apr 12, 2023 · Needham analyst Mayank Tandon initiates coverage on Globant SA (NYSE:GLOB) with a Buy rating and a price target of $205.; The analyst believes Globant's …

businessinsider.com

$200.00
OFF

Globant (NYSE:GLOB) Stock Rating Lowered By StockNews.com

1 week from now

Nov 2, 2024 · Needham & Company LLC increased their price objective on shares of Globant from $200.00 to $245.00 and gave the stock a “buy” rating in a report on Friday, August 16th.

etfdailynews.com

$205
OFF

Needham Initiates Coverage On Globant With Buy Rating

1 week from now

Apr 12, 2023 · Needham analyst Mayank Tandon initiates coverage on Globant (NYSE:GLOB) with a Buy rating and announces Price Target of $205.

benzinga.com

$85.00
OFF

Haemonetics (NYSE:HAE) Earns "Buy" Rating From Needham

1 week from now

1 day ago · Bank of America assumed coverage on shares of Haemonetics in a research note on Wednesday, September 11th. They issued a "neutral" rating and a $85.00 target price on the …

marketbeat.com

$25.00
OFF

Thryv (NASDAQ:THRY) Given Buy Rating At Needham & Company …

1 week from now

Nov 8, 2024 · Robert W. Baird reduced their price objective on Thryv from $25.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday. Craig Hallum …

marketbeat.com

$126.00
OFF

Blueprint Medicines’ Promising Pipeline Developments Support …

1 week from now

2 days ago · In another report released yesterday, J.P. Morgan also initiated coverage with a Buy rating on the stock with a $126.00 price target. See the top stocks recommended by analysts >>

businessinsider.com

$10.51
OFF

Needham & Company LLC Reiterates Buy Rating For Artiva …

1 week from now

2 days ago · NASDAQ ARTV opened at $10.51 on Wednesday. The firm has a 50 day moving average price of $12.60. Artiva Biotherapeutics has a 1-year low of $9.68 and a 1-year high of …

defenseworld.net

$29.00
OFF

Celcuity's (CELC) Buy Rating Reaffirmed At Needham & Company …

1 week from now

2 days ago · They set an "outperform" rating and a $29.00 price target for the company. HC Wainwright reaffirmed a "buy" rating and issued a $27.00 price target on shares of Celcuity in …

marketbeat.com

$126.00
OFF

Blueprint Medicines (NASDAQ:BPMC) Given Buy Rating At …

1 week from now

2 days ago · JPMorgan Chase & Co. initiated coverage on Blueprint Medicines in a report on Thursday. They set an "overweight" rating and a $126.00 price target for the company. Finally, …

marketbeat.com

FAQs about Needham & Company LLC Boosts Globant (NYSE:GLOB) Price Coupon?

Is Globant (Glob) a good stock to buy?

Globant (NYSE:GLOB – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Thursday. Other research analysts have also recently issued research reports about the stock. ...

How much will Globant (Globant) earn per share?

On average, research analysts anticipate that Globant will post 5.05 earnings per share for the current fiscal year. Large investors have recently added to or reduced their stakes in the business. Quarry LP boosted its stake in shares of Globant by 529.6% in the 2nd quarter. ...

Does quarry LP own Globant?

Quarry LP now owns 170 shares of the information technology services provider’s stock worth $30,000 after buying an additional 143 shares during the last quarter. Ridgewood Investments LLC purchased a new stake in shares of Globant during the 2nd quarter valued at $31,000. ...